What is Lynparza, and how does it work?
Lynparza is a prescription medicine used to treat adults who have:
- advanced ovarian cancer, fallopian tube cancer, or primary peritoneal cancer with a certain type of inherited (germline) or acquired (somatic) abnormal BRCA gene. Lynparza is used alone as maintenance treatment after the cancer has responded to your first treatment with platinum-based chemotherapy. Your healthcare provider will perform a test to make sure that Lynparza is right for you.
- advanced ovarian cancer, fallopian tube cancer or primary peritoneal cancer with a certain type of abnormal BRCA gene or a positive laboratory tumor test for genomic instability called HRD. Lynparza is used in combination with another anti-cancer medicine, bevacizumab, as maintenance treatment after the cancer has responded to your first treatment with platinum-based chemotherapy. Your healthcare provider will perform a test to make sure that Lynparza is right for you.
- ovarian cancer, fallopian tube cancer, or primary peritoneal cancer, as maintenance treatment, when the cancer has come back. Lynparza is used after the cancer has responded to treatment with platinum-based chemotherapy.
- advanced ovarian cancer with a certain type of abnormal inherited BRCA gene, and have received treatment with 3 or more prior types of chemotherapy medicines. Your healthcare provider will perform a test to make sure that Lynparza is right for you.
- a certain type of abnormal inherited BRCA gene, human epidermal growth factor receptor 2 (HER2)-negative breast cancer that has spread to other parts of the body (metastatic). You should have received chemotherapy medicines, either before or after your cancer has spread. If you have hormone receptor (HR)-positive disease, you should have been treated with hormonal therapy. Your healthcare provider will perform a test to make sure that Lynparza is right for you.
- metastatic pancreatic cancer with a certain type of abnormal inherited BRCA gene. Lynparza is used as maintenance treatment after your cancer has not progressed on at least 16 weeks of treatment with platinum-based chemotherapy. Your healthcare provider will perform a test to make sure that Lynparza is right for you.
It is not known if Lynparza is safe and effective in children.
What are the side effects of Lynparza?
Lynparza may cause serious side effects.
The most common side effects of Lynparza are:
- nausea or vomiting. Tell your healthcare provider if you get nausea or vomiting. Your healthcare provider may prescribe medicines to treat these symptoms.
- low number of red or white blood cells
- stomach-area (abdominal) pain
- tiredness or weakness
- sore throat or runny nose
- joint, muscle, and back pain
- mouth sores
- respiratory tract infections
- changes in kidney function blood test
- changes in the way food tastes
- loss of appetite
- low number of platelets
- indigestion or heartburn
These are not all of the possible side effects of Lynparza.
Call your healthcare provider for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
What is the dosage for Lynparza?
Information on FDA-approved tests for the detection of genetic mutations is available at http://www.fda.gov/companiondiagnostics.
Select patients for treatment with Lynparza based on the presence of deleterious or suspected deleterious HRR gene mutations, including BRCA mutations, or genomic instability based on the indication, biomarker, and sample type (Table 1).
Table 1 : Biomarker Testing for Patient Selection
|First-line maintenance treatment of germline or somatic BRCAm advanced * ovarian cancer||BRCA1 m, BRCA2m||X||X|
|First-line maintenance treatment of HRD-positive advanced ovarian cancer in combination with bevacizumab*||BRCA1m, BRCA2m and/or genomic instability||X|
|Maintenance treatment of recurrent ovarian cancer||No requirement for biomarker testing|
|Advanced gBRCAm ovarian cancer||gBRCA1m, gBRCA2m||X|
|gBRCAm HER2-negative metastatic breast cancer||gBRCAlm, gBRCA2m||X|
|First-line maintenance treatment of germline BRCA-mutated metastatic pancreatic adenocarcinoma||gBRCAlm, gBRCA2m||X|
|Germline or somatic HRR gene-mutated metastatic castration-resistant prostate * cancer||ATMm, BRCAlm, BRCA2m, BARDlm, BRIPlm, CDK12m, CHEK1 m, CHEK2m, FANCLm, PALB2m, RAD5lBm, RAD5lCm, RAD5lDm, RAD54Lm||X|
|* Where testing fails or tissue sample is unavailable/insufficient, or when germline testing is negative, consider using an alternative test.|
- The recommended dosage of Lynparza is 300 mg taken orally twice daily, with or without food.
- If a patient misses a dose of Lynparza, instruct patient to take their next dose at its scheduled time.
- Instruct patients to swallow tablets whole. Do not chew, crush, dissolve, or divide tablet.
First-Line Maintenance Treatment Of BRCA-mutated Advanced Ovarian Cancer
- Continue treatment until disease progression, unacceptable toxicity, or completion of 2 years of treatment.
- Patients with a complete response (no radiological evidence of disease) at 2 years should stop treatment. Patients with evidence of disease at 2 years, who in the opinion of the treating healthcare provider can derive further benefit from continuous treatment, can be treated beyond 2 years.
First-Line Maintenance Treatment Of HRD-positive Advanced Ovarian Cancer In Combination With Bevacizumab
- Continue Lynparza treatment until disease progression, unacceptable toxicity, or completion of 2 years of treatment.
- Patients with a complete response (no radiological evidence of disease) at 2 years should stop treatment.
- Patients with evidence of disease at 2 years, who in the opinion of the treating healthcare provider can derive further benefit from continuous Lynparza treatment, can be treated beyond 2 years.
- When used with Lynparza, the recommended dose of bevacizumab is 15 mg/kg every three weeks.
- Bevacizumab should be given for a total of 15 months including the period given with chemotherapy and given as maintenance. Refer to the Prescribing Information for bevacizumab when used in combination with Lynparza for more information.
Recurrent Ovarian Cancer, Germline BRCAm Advanced Ovarian Cancer, HER2-negative Metastatic Breast Cancer, Metastatic Pancreatic Adenocarcinoma, And HRR Gene-mutated Metastatic Castration-Resistant Prostate Cancer
Continue treatment until disease progression or unacceptable toxicity for:
- Maintenance treatment of recurrent ovarian cancer
- Advanced germline BRCA-mutated ovarian cancer
- Germline BRCA-mutated HER-2 negative metastatic breast cancer
- First-line maintenance treatment of germline BRCA-mutated metastatic pancreatic adenocarcinoma.
- HRR gene-mutated metastatic castration-resistant prostate cancer
- Patients receiving Lynparza for mCRPC should also receive a gonadotropin-releasing hormone (GnRH) analog concurrently or should have had bilateral orchiectomy.
Dosage Modifications For Adverse Reactions
- To manage adverse reactions, consider interruption of treatment or dose reduction. The recommended dose reduction is 250 mg taken twice daily.
- If a further dose reduction is required, then reduce to 200 mg taken twice daily.
Dosage Modifications For Concomitant Use With Strong Or Moderate CYP3A Inhibitors
Avoid concomitant use of strong or moderate CYP3A inhibitors with Lynparza. If concomitant use cannot be avoided, reduce Lynparza dosage to:
- 100 mg twice daily when used concomitantly with a strong CYP3A inhibitor.
- 150 mg twice daily when used concomitantly with a moderate CYP3A inhibitor.
After the inhibitor has been discontinued for 3 to 5 elimination half-lives, resume the Lynparza dose taken prior to initiating the CYP3A inhibitor.
Dosage Modifications For Renal Impairment
Moderate Renal Impairment
- In patients with moderate renal impairment (CLcr 31-50 mL/min), reduce the Lynparza dosage to 200 mg orally twice daily.
What drugs interact with Lynparza?
Use With Anticancer Agents
Clinical studies of Lynparza with other myelosuppressive anticancer agents, including DNA damaging agents, indicate a potentiation and prolongation of myelosuppressive toxicity.
Effect Of Other Drugs On Lynparza
Strong And Moderate CYP3A Inhibitors
- Coadministration of CYP3A inhibitors can increase olaparib concentrations, which may increase the risk for adverse reactions.
- Avoid coadministration of strong or moderate CYP3A inhibitors.
- If the strong or moderate inhibitor must be coadministered, reduce the dose of Lynparza.
Strong And Moderate CYP3A Inducers
- Concomitant use with a strong or moderate CYP3A inducer decreased olaparib exposure, which may reduce Lynparza efficacy.
- Avoid coadministration of strong or moderate CYP3A inducers.
Is Lynparza safe to use while pregnant or breastfeeding?
- Based on findings in animals and its mechanism of action, Lynparza can cause fetal harm when administered to a pregnant woman.
- There are no available data on Lynparza use in pregnant women to inform the drug-associated risk.
- In an animal reproduction study, the administration of olaparib to pregnant rats during the period of organogenesis caused teratogenicity and embryo-fetal toxicity at exposures below those in patients receiving the recommended human dose of 300 mg twice daily.
- No data are available regarding the presence of olaparib in human milk, or on its effects on the breastfed infant or on milk production.
- Because of the potential for serious adverse reactions in the breastfed infants from Lynparza, advise a lactating woman not to breastfeed during treatment with Lynparza and for one month after receiving the last dose.
- Chinese Company May Help Ease U.S. Shortage of Cancer Drug
- Opdivo Could Boost Outcomes for People Battling Hodgkin Lymphoma
- More U.S. Kids, Teens Are Getting Weight-Loss Surgeries
- Could a Nitroglycerin Patch Ease Hot Flashes?
- One Form of Menopause Hormone Therapy Might Raise Blood Pressure
- More Health News »
Lynparza is a prescription medicine used to treat adults who have advanced ovarian cancer, fallopian tube cancer, primary peritoneal cancer, a certain type of abnormal inherited BRCA gene, human epidermal growth factor receptor 2 (HER2)-negative breast cancer, or metastatic pancreatic cancer with a certain type of abnormal inherited BRCA gene. The most common side effects of Lynparza are nausea or vomiting.
Multimedia: Slideshows, Images & Quizzes
Breast Cancer Awareness: Symptoms, Diagnosis, and Treatment
Learn about breast cancer causes, symptoms, tests, recovery, and prevention. Discover the types of treatments such as surgery and...
Pancreatic Cancer Symptoms, Causes, and Treatment
Learn about pancreatic cancer signs, symptoms, causes, statistics, treatments (chemotherapy, radiation, surgery, biological...
Ovarian Cancer Symptoms, Signs, Stages
Ovarian cancer symptoms and signs include abdominal pain, bloating, frequent urination, and a feeling of fullness. Ovarian cancer...
Cervical Cancer Symptoms, Stages, and Treatment
Cervical cancer is typically caused by HPV infections. Learn about vaccines to prevent cervical cancer. Get information about...
Signs of Cancer in Women: Symptoms You Can't Ignore
Colon and stomach cancer symptoms can surprise women but can be treated if detected early. Learn about breast cancer signs and...
Cancer-Fighting Foods: Resveratrol, Green Tea, and More
Experts have praised certain foods for their ability to reduce cancer risks. Learn which foods and eating strategies may help...
Top 10 Cancers Quiz
Take this quiz to learn the causes of cancer. Get the facts about the causes, symptoms, and treatments for the world's most...
Breast Cancer Quiz: Symptoms & Signs
This Breast Cancer Quiz features signs, symptoms, facts, causes, common forms, terms, risk factors, statistics, and more. ...
Ovarian Cancer Quiz: Test Your Medical IQ
How common is ovarian cancer and who is at risk? Take our Ovarian Cancer Quiz to learn the causes, symptoms, and treatment for...
Picture of Pancreatic Cancer
An abdominal CT scan shows a small, vaguely seen 2-cm pancreatic adenocarcinoma (mass) causing obstruction of both the common...
Cancer: Does This Cause Cancer?
Everything gives you cancer, right? Not really. WebMD's slide show tells you about the research into cancer and cell phones,...
Cancer: How to Lower and Cut Your Risk of Cancer
About a third of all cases of cancer can be prevented. Find out how to lower your chances of getting it.
Cancer: Cancer 'Remedies' That Don't Work
You may have read about an all-natural cure for cancer. While many therapies are helpful, some aren't worth your time or money....
Breast Cancer: Where It Can Spread
When breast cancer spreads, or metastasizes, it often goes to these five places: the lymph nodes, bones, liver, lungs, and brain....
Related Disease Conditions
Cancer is a disease caused by an abnormal growth of cells, also called malignancy. It is a group of 100 different diseases, and is not contagious. Cancer can be treated through chemotherapy, a treatment of drugs that destroy cancer cells.
There are many types of ovarian cancer, epithelial carcinoma is the most common. Women with a family history of ovarian cancer have an increased risk of developing the disease. Some ovarian cancer symptoms include abdominal pain, nausea, diarrhea, constipation, and abnormal vaginal bleeding, however, they usually do not present until the disease has progressed. Early diagnosis is important for successful treatment.
Breast Cancer in Men
Second Source WebMD Medical Reference
Pancreatic cancer is a malignant tumor of the pancreas. Pancreatic cancer has been called a "silent" disease because early pancreatic cancer usually does not cause early symptoms. Typically, pancreatic cancer has metastasized (spread to adjacent organs, such as the liver) by the time most people receive a dignosis of pancreatic cancer. Symptoms and signs usually appear later in the course of the disease and include jaundice, back pain, nausea, weight loss, itching, and loss of appetite. Treatment depends upon the type of pancreatic cancer but may include surgery, chemotherapy, and/or radiation therapy.
Cancer Risk Factors and Causes
Though it's difficult to say why some people develop cancer while others don't, research shows that certain risk factors increase a person's odds of developing cancer. These risk factors include growing older, family history of cancer, diet, alcohol and tobacco use, and exposure to sunlight, ionizing radiation, certain chemicals, and some viruses and bacteria.
What Are the Symptoms of Stage 1 Ovarian Cancer?
At stage 1 of ovarian cancer, the cancer is present only in the ovaries i.e. it has not spread in any other organs. Signs and symptoms at this stage may include a mass felt in the abdomen, distension or swelling of abdomen, abnormal vaginal bleeding (between menstrual periods or after menopause) and other signs. Stage 1 ovarian cancer has no symptoms in many women, however; often they may not experience symptoms until the cancer has spread significantly.
Can Fibroadenomas Turn Into Breast Cancer?
A fibroadenoma is the most common type of benign, non-cancerous lump of the breast. Although it is rare, complex fibroadenomas and phyllodes tumors have a chance to develop into malignant breast cancer.
Breast Cancer Prevention
Lifestyle changes, a healthy antioxidant-rich diet, exercise, and weight reduction can help reduce a woman's risk of developing breast cancer. It's important to be aware of how risk factors such as family history, lifestyle factors, breast conditions, radiation therapy, and hormonal factors may influence your chances of developing breast cancer. Mammography and breast self-examinations are crucial steps in breast cancer prevention.
Breast Cancer and Coping With Stress
Being diagnosed with breast cancer is stressful. Learning relaxation techniques, exercising, eating well, getting adequate sleep, receiving psychotherapy, and maintaining a positive attitude can help you cope. Creating documents, such as an advance directive, living will, and durable power of attorney will outline your wishes in the event that you are no longer able to make decisions regarding your care.
Breast Cancer and Lymphedema
Lymphedema is a common chronic, debilitating condition in which excess fluid called lymph collects in tissues and causes swelling in them. It is common after a mastectomy, lumpectomy or breast cancer surgery and radiation therapy.
Breast Cancer Recurrence
Breast cancer most often recurs within the first 3-5 years after the initial treatment. Changes in the look, feel, or appearance of the breast may indicate breast cancer recurrence. Factors related to recurrence include tumor size, tumor grade, hormone receptor status, lymph node involvement, and oncogene expression. Check out the center below for more medical references on breast cancer, including multimedia (slideshows, images, and quizzes), related diseases, treatment, diagnosis, medications, and prevention or wellness.
Breast Cancer Stages
Breast cancer staging is the determination of the extent and spread of cancer. An individual's health care team uses stages to summarize the extent of cancer in a standardized way that is recognized by all health care providers. They use this staging to determine the treatment most appropriate for the type of cancer. Cancer staging helps to determine the prognosis, or outlook, of cancer, including rates of recurrence and survival rates.
HER2-Positive Breast Cancer
In about 10%-20% of breast cancers, the cancer cells test positive for HER2, sometimes referred to as the HER2/neu protein. HER2 is a growth-promoting protein located on the surface of some cancer cells. HER2-positive breast cancers tend to grow more rapidly and spread more aggressively than breast cancers that are HER2-negative. Doctors do not know what specifically causes some breast cancers to express this protein while others do not.
Breast Cancer Early Warning Signs and Symptoms
In most cases, there are no early warning signs of breast cancer. Breast cancer may not produce any early symptoms, and in many cases, it is first discovered on screening mammography. The most common sign of breast cancer is a new lump or mass in the breast.
Breast Cancer Treatment
Breast cancer treatments depend upon the type of breast cancer that is present as well as the stage (extent of spread) of the tumor. Treatment for early breast cancer typically involves surgery to remove the tumor. After surgery, medical professionals may administer radiation therapy, chemotherapy, or targeted therapy.
What Questions Should I Ask My Doctor About Breast Cancer?
A diagnosis of breast cancer can be overwhelming, so it's important to write down all your questions before meeting with your doctor.
What Should I Know About Breast Cancer?
Breast cancer is the most common non-skin cancer of American women, but it can also occur in men. Every year in the U.S., there are over 266,000 new diagnoses of breast cancer. A woman has a risk of one in eight for developing breast cancer at some point during her lifetime.
Breast Cancer Treatment by Stage
Treatment of breast cancer depends upon the stage of the cancer at the time of diagnosis. Some of the various treatments include: hormone therapy, radiation therapy, surgery, chemotherapy, HER2-targeted therapy, neoadjuvant therapy, and adjuvant therapy.
Cancer pain is a common experience that may result from the disease, treatment, or diagnostic procedure. Check out the center below for more medical references on cancer, including multimedia (slideshows, images, and quizzes), related disease conditions, treatment and diagnosis, medications, and prevention or wellness.
Breast Cancer in Young Women
About 5% of cases of breast cancer occur in women under the age of 40 years old. Some risk factors for breast cancer in young women include a personal history of breast cancer or breast disease, family history of breast cancer, prior radiation therapy, and the presence of BRCA1/BRCA2 gene mutations. Breast self-exams, clinical breast exams, and screening mammograms may help detect breast cancer. Treatment may include surgery, chemotherapy, radiation, and hormone therapy.
Breast Cancer Clinical Trials
Breast cancer clinical trials are research programs designed to evaluate new medical treatments, drugs, or devices for the treatment of breast cancer. Clinical trials are designed to test the safety and efficacy of new treatments as well as assess potential side effects. Clinical trials also compare new treatment to existing treatments to determine if it's any better. There are many important questions to ask your doctor before taking part in a breast cancer clinical trial.
Breast Cancer During Pregnancy
Breast cancer occurs in about 1 in every 1,000 pregnant women. Treatment of breast cancer during pregnancy involves surgery, but it is very difficult to protect the baby from the dangerous effects of radiation and chemotherapy. It can be an agonizing to decide whether or not to undergo breast cancer treatment while one is pregnant.
Breast Cancer Growth Rate
The available evidence suggests that breast cancer may begin to grow around 10 years before it is detected. However, the time for development differs from tumor to tumor.
How Can You Detect Breast Cancer Early?
Breast cancer develops from the cells of the breasts and can spread to other parts of the body (metastasis). It is one of the most common cancers diagnosed in women in the United States. A lump in the breast or armpit is often the first sign. Treatment success depends largely on early detection.
Genetic Testing: Families With Breast Cancer
Breast cancer can be a killer and the decision to get tested to see if a patient is prone to the disease should be discussed with a doctor -- particularly if the woman has a history of breast cancer in her family. Genetic testing can only tell so much about breast cancer risk, however.
Treatment & Diagnosis
- Pancreatic Cancer
- Anal Cancer
- Ovarian Cancer
- Cervical Cancer
- Uterine Cancer (Endometrial Cancer)
- Breast Cancer: A Feisty Women's Discussion
- Breast Cancer: Mother-daughter relationships
- Vaginal Cancer
- Breast Cancer: Early Stage Treatments
- Cancer and Green Tea
- Breast Cancer, Taking Control: Self-Advocacy 101
- Breast Cancer: The Male View on Survival and Support
- Breast Cancer: Clinical Trials - Today's Cutting Edge
- Breast Cancer: Early Diagnosis and Prevention
- Breast Cancer FAQs
- Ovarian Cancer FAQs
- Cancer FAQs
- Ovarian Cancer Symptoms, Early Warning Signs, and Risk Factors
- Ovarian Cancer: Exercise May Help Prevent
- Advanced Breast Cancer in Young Women Increasing
- What Are the Early Warning Signs of Ovarian Cancer?
- Can Ovarian Cysts Be the Start of Cancer?
- How Many Breast Cancer Deaths Are there Each Year?
- Where Can Breast Cancer Spread To?
- Can You Get Ovarian Cancer after Tubal Ligation?
- Is Peritoneal Cancer Hereditary?
- Can You Prevent Ovarian Cancer?
- Why Is Breast Cancer More Common in Females than Males?
- Who Does Breast Cancer Affect?
- How Does Breast Cancer Form?
- How Many Breast Cancer Stages Are There?
Medications & Supplements
Health Solutions From Our Sponsors
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.